Carsten Bahr

Carsten Bahr has a diverse work experience spanning multiple industries. Carsten began their career as a PhD student at the DKFZ German Cancer Research Center, where they conducted research on stem cells and cancer. Carsten'sdoctoral studies resulted in a publication in Nature.

After completing their PhD, Carsten worked as a Strategy Consultant at Siemens Advanta Consulting, specializing in the healthcare industry. Carsten led the development and execution of data strategies and digital use cases for healthcare clients, improving their operational performance and generating additional revenue streams. Carsten also led marketing department transformations, focusing on advanced customer segmentation and efficiency improvements.

Carsten then joined Novartis and held two roles. As a Digital Innovation Manager, they led evidence generation projects in digital health, enhancing data quality and patient experiences in clinical trials. Carsten also executed data-driven projects to derive medical and health economics and outcomes research insights. In their subsequent role as a Digital Health Solution Manager, Carsten continued to lead evidence generation projects and executed data-driven projects using innovative data sources.

Currently, Carsten works at Fresenius Group as the Director of Corporate Development. Carsten is part of the Innovation and Technology team, analyzing technology and innovation trends in healthcare. Carsten identifies growth opportunities for Fresenius SE and manages internal innovation projects within operating companies. Carsten'smain focus is on biologics and cell & gene therapy. Carsten's responsibilities include innovation scouting and business plan development and implementation.

Overall, Carsten Bahr's work experience showcases their expertise in strategy development, project management, and innovation in the healthcare industry.

Carsten Bahr completed their education in the following institutions and fields of study:

- From 2014 to 2018, they pursued a Doctor of Philosophy (PhD) degree in Cell/Cellular and Molecular Biology at the DKFZ German Cancer Research Center.

- In 2013 and 2014, Carsten attended the Karolinska Institutet, focusing on Oncology and Cancer Biology.

- Between 2012 and 2014, they obtained a Master of Science (MS) degree in Molecular Biosciences, with a major in Cancer Biology from Heidelberg University.

- From 2009 to 2012, Carsten earned a Bachelor of Science (BS) degree in Humanbiologie (Biomedical Science) at The Philipp University of Marburg.

Additionally, Carsten Bahr holds certifications in the following areas:

- Leadership and Emotional Intelligence from Coursera (obtained in 2020).

- Design and Interpretation of Clinical Trials from Coursera (obtained in 2020).

- Innovation Management from Coursera (obtained in 2020).

- Effective Problem-Solving and Decision-Making from Coursera (obtained in 2017).

- Finance for Non-Financial Professionals from Coursera (obtained in 2017).

- Project Management: The Basics for Success from Coursera (obtained in 2017).

- FELASA (Category B) certification obtained in 2014.

- Project Leader and responsible Person for Biosafety according to §15 GenTSV obtained in 2011.